DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on November 15, 2006; DOI: 10.1124/dmd.106.012864


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.106.012864v1
35/2/275    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Youdim, K.
Right arrow Articles by Hyland, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Youdim, K.
Right arrow Articles by Hyland, R.


Received for publication September 13, 2006.
Revised November 9, 2006.
Accepted for publication November 10, 2006.

Induction of cytochrome P450; Assessment in an immortalized human hepatocyte cell line (Fa2N4) using a novel higher throughput cocktail assay

Kuresh Youdim 1*, Christine A Tyman 1, Barry C Jones 1, Ruth Hyland 1

1 Pfizer

* Address correspondence to: E-mail: kuresh.youdim{at}pfizer.com

Abstract

Over recent years the application of cocktail studies to measure biological markers, have become increasingly popular. The current study investigated a novel approach in assessing P450 enzyme induction in an immortalized cell line, using a 'cocktail' of five cytochrome P450 substrate probes compared with the traditional single probe approach. The findings reported herein support use of a cocktail approach to assess the induction of the major P450s; namely CYP3A4, 1A2, 2C9. Cytochrome P450s 2C19 and 2D6 could also be followed as part of the cocktail approach reported. Response to prototypical inducers did not differ to those observed in the presence of the specific probes alone. Consequently this approach requires significantly fewer sample numbers, if screening the induction potential of >1 cytochrome P450. Moreover, these studies highlight the utility of the immortalized cell line, Fa2N4 as a robust model system for induction studies. In conclusion, the current experimental set-up is an improvement on current approaches employed to assess cytochrome P450 induction, significantly increasing sample throughput.


Key words: CYP induction, drug interactions, hepatocytes





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.